Company or ticker...

Veracyte

Veracyte develops genomic diagnostic tests that help guide cancer and disease treatment decisions.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

VCYT

4.8B

6.8

56

43.55%

Key Facts

M. Cap

PS

PE

YTD

4.8B

6.8

56

43.55%

10MA

20MA

50MA

200MA

$VCYT